ARCHIVES

Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care”

This article is from The Cancer Letter archive.

Vol. 40 No. 14 | April 4, 2014

Download PDF Visit The Full Archive

Related Articles

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

In Brief: Gregory Curt May Return As Director Of COP; Koop Locked In as Surgeon General Until Nov.

January 20, 1989

Barnett Kramer Retires From NIH

January 7, 2011

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013